# Brad Kreger

> Brad Kreger is a medical device and manufacturing executive who became CEO of Baltimore-based CoapTech in November 2025, taking over from co-founder Howard Carolan. He brings nearly three decades of operations experience, most recently turning around metal 3D-printing company Velo3D as its CEO, with earlier senior roles at Fluidigm/Standard BioTools, Thermo Fisher Scientific, and Affymetrix. At CoapTech he leads commercialization of the percutaneous ultrasound gastrostomy (PUG) system, an ultrasound-guided method of placing feeding tubes at the bedside that has been used in more than 1,000 patients.

- **Role:** Chief Executive Officer at CoapTech
- **Organizations:** CoapTech, Velo3D, Fluidigm Corporation / Standard BioTools, Thermo Fisher Scientific, Affymetrix Inc.
- **Nationality:** American
- **Education:** Bachelor's degree in biotechnology, MBA, business administration and management
- **Known for:** Led Velo3D's operational turnaround, reducing field issue resolution downtime by roughly 50%, Drove repeat-customer momentum at Velo3D, with more than half of recent bookings coming from existing customers, Scaled mass cytometry production and operational infrastructure at Fluidigm

## Career timeline

- **1990s-2010s** — Over two decades at Affymetrix, holding roles including Director of Operations, Process Engineering, and Reagent Manufacturing
- **2016** — After Thermo Fisher Scientific acquired Affymetrix, served as Director of Sequence Engineering at Thermo Fisher
- **2010s-2022** — Senior Vice President, Global Operations at Fluidigm (later Standard BioTools), scaling mass cytometry production
- **2022-12** — Joined Velo3D as Executive Vice President of Operations to consolidate processes after rapid expansion
- **2023-12** — Named interim CEO of Velo3D following founder Benny Buller's departure
- **2024-06** — Formally appointed permanent CEO of Velo3D
- **2025-11** — Appointed CEO of CoapTech, succeeding co-founder Howard Carolan

## Achievements

- Led Velo3D's operational turnaround, reducing field issue resolution downtime by roughly 50%
- Drove repeat-customer momentum at Velo3D, with more than half of recent bookings coming from existing customers
- Scaled mass cytometry production and operational infrastructure at Fluidigm
- Holds long operations leadership tenure across Affymetrix and Thermo Fisher
- Now leading CoapTech's commercialization of the PUG system, used in more than 1,000 patients

## Latest updates

- **2025-11** — Appointed Chief Executive Officer of CoapTech, succeeding co-founder Howard Carolan, who remains as an advisor.

## Links

- Website: https://coaptech.com
- LinkedIn: http://www.linkedin.com/in/brad-kreger

---

Profile page: https://yespress.io/brad-kreger
Published by YesPress — https://yespress.io
Last updated: 2026-06-14